Clinical Trials Browser

Phase 1/2 × Nasopharyngeal Carcinoma × Immunotherapy, Adoptive × Clear all

NCT02980315 2016-12-02

A New EBV Related Technologies of T Cells in Treating Malignant Tumors and Clinical Application

Phase 1/2 Unknown

Nasopharyngeal Carcinoma, Nasopharyngeal Neoplasms